Skip to content
Research Article Open access CC BY 4.0

The Protective Effect of 9-Diaminoacridine against Ehrlich Ascites Carcinoma (EAC) Induced Spleen Injury in Female Mice

Ehab Tousson, Afaf El-Atrash, Ibrahim El Tantawy El Sayed, Ezar Hafez, Hebat Allah El Basyouny, Ramadan M. Kandyel

Asian Oncology Research Journal · pp. 54–65 · Published 31 Mar 2021

Abstract

Background and Objective: The study aims to evaluate the protective activity of 9-Diaminoacridine (N1-(acridin-9-yl) propane-1, 3-diamine hydrochloride; 9-DAAD) against Ehrlich Ascites Carcinoma (EAC) bearing mice. Materials and Methods: A total forty mice were randomly divided into four groups (1st group, control mice were injected with 0.1% DMSO 15 ml/ Kg bw subcutaneously; 2nd group, mice were administered with 9-DAAD (30 mmol/ kg bw every 3 day) subcutaneously for 2 weeks; 3rd group, mice were injected interaperitonealy with 2.5×106 EAC cells/mouse; 4th group, were injected with EAC as the 3rd group then administered with 9-DAAD for another 2 weeks). Results: The results showed that; EAC exhibit a significant reduction in RBCs, Hb, HCT, MCV, MCH, MCHC levels. Moreover, EAC exhibit a significant elevation in WBCs and PLT levels when compared to the control group. Many histopathological alterations were observed within the splenic tissue of the EAC group as cellular degeneration of red and white pulps, several necrotic cells, vacuolar degeneration, and notable amyloid deposition. In addition, there is a significant increase in the activity of caspase-3 and vascular endothelial growth factor (VEGF) expressions. On the other hand; treatment of EAC mice with 9-DAAD regularized serum levels of the above-mentioned parameters and also restore the splenic tissue normal histological architecture. Conclusion: The results indicated that the 9-DAAD possesses a protective activity against EAC induced changes in blood, biochemical parameters and splenic injury. Further studies are warranted to explore its mode of action and safety for medicinal use in cancer therapy.

9-Diaminoacridine (9-DAAD) spleen ehrlich ascites carcinoma (EAC) tumor markers caspase-3 vascular endothelial growth factor (VEGF).

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.